Boehringer’s Innovation Strategy Does Not Avoid Areas With Heavy Competition

 
• By Joseph Haas
  
Boehringer Ingelheim headquarters in Ingelheim, Germany
BI's R&D strategy centers on novel targets and breakthrough therapies for unmet needs • Source: Boehringer Ingelheim (dieth+schröder-fotografie)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business